SAN DIEGO, CA / ACCESS Newswire / April 1, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision-guided medicine, announces a new Anser® therapeutic drug monitoring (TDM) test for ...
Saliva-based diagnostic detects genes related to the disease and calculates risk. Prometheus has selected DNA Genotek’s Oragene®•DNA product as the sample-collection kit for MyCeliacID™, a ...
SAN DIEGO, CA / ACCESSWIRE / July 27, 2023 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision healthcare, announced the launch of PredictrPK ADA, a precision-guided dosing test for ...
Prometheus Launches the First Serogenetic Test to Predict Risk of Complications From Crohn's Disease
SAN DIEGO, Aug. 31 Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the commercial launch of its proprietary PROMETHEUS® Crohn's Prognostic test. This ...
The San Diego-based pharmaceutical company Prometheus Laboratories has launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab. 1. The PROMETHEUS ...
ArianeGroup has successfully carried out the first ignition campaign of the reusable Prometheus® engine on the reusable Themis rocket core stage demonstrator – a key step in providing Europe with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results